JAN (NYSE:JAN – Get Free Report) had its price objective cut by stock analysts at Scotiabank from $30.00 to $29.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has a “sector outperform” rating on the stock. Scotiabank’s target price would suggest a potential upside of 14.11% from the stock’s previous close.
Several other equities research analysts also recently issued reports on the company. JPMorgan Chase & Co. assumed coverage on JAN in a report on Tuesday, April 14th. They issued an “overweight” rating and a $26.00 price target for the company. Royal Bank Of Canada increased their price target on JAN from $27.00 to $30.00 and gave the stock an “outperform” rating in a report on Friday, May 8th. Wall Street Zen downgraded JAN from a “hold” rating to a “sell” rating in a report on Saturday, June 6th. Bank of America started coverage on JAN in a report on Tuesday, April 14th. They set a “buy” rating and a $29.00 price objective for the company. Finally, BNP Paribas Exane started coverage on JAN in a report on Tuesday, April 14th. They set an “outperform” rating and a $27.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $29.17.
Get Our Latest Stock Analysis on JAN
JAN Stock Down 0.5%
JAN (NYSE:JAN – Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.23 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.23. The business had revenue of $200.35 million during the quarter, compared to the consensus estimate of $157.96 million. JAN has set its FY 2026 guidance at 0.930-0.970 EPS.
Insider Transactions at JAN
In related news, Director Katherine M. Sandstrom purchased 13,500 shares of the firm’s stock in a transaction on Monday, March 23rd. The stock was purchased at an average cost of $20.00 per share, for a total transaction of $270,000.00. Following the completion of the purchase, the director directly owned 21,000 shares in the company, valued at $420,000. This trade represents a 180.00% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John V. Arabia purchased 60,000 shares of the firm’s stock in a transaction on Monday, March 23rd. The stock was bought at an average price of $20.00 per share, with a total value of $1,200,000.00. Following the completion of the purchase, the director owned 67,500 shares of the company’s stock, valued at approximately $1,350,000. This represents a 800.00% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders purchased 187,000 shares of company stock valued at $3,740,000. 3.00% of the stock is owned by insiders.
JAN News Roundup
Here are the key news stories impacting JAN this week:
- Positive Sentiment: Raymond James upgraded JAN to “strong-buy,” which can attract new buyers and support the stock. Tickerreport.com
- Neutral Sentiment: The company’s recent quarterly results were solid, with EPS in line with expectations and revenue above estimates, giving investors a favorable backdrop ahead of the fiscal 2026 guidance range. MarketBeat JAN Stock Page
About JAN
Upon completion of this offering, we will be the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT whose entire portfolio is owned and operated under RIDEA structures. We have an initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. Our communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025.
Featured Stories
- Five stocks we like better than JAN
- The AI Trade Is Getting Harder to Pick, But These 3 ETFs Take a Different Route
- 3 Hotel REITs Poised to Benefit from the World Cup
- Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story
- 3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound
Receive News & Ratings for JAN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JAN and related companies with MarketBeat.com's FREE daily email newsletter.
